Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)
Clinical trial NCT00610649 · COMPLETED
Trial details
- NCT number
- NCT00610649
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-20
- Primary completion
- 2008-11-18
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.